Prestige Wealth Management Group LLC Bristol Myers Squibb CO Call Options Transaction History

Prestige Wealth Management Group LLC

  • $460 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$40.25 - $52.99 $40,250 - $52,990
1,000 New
1,000 $41,000
Q4 2023

Apr 26, 2024
BUY
$48.48 - $57.85 $300,576 - $358,670
6,200 New
6,200 $318,000
Q4 2023

Feb 08, 2024
BUY
$48.48 - $57.85 $300,576 - $358,670
6,200 New
6,200 $318,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email